Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Quarterly results

Phathom Pharmaceuticals, Inc. (PHAT) Create: Alert

All | News | Filings
Date FiledTypeDescription
07/21/2023 4/A Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
07/17/2023 4 Henderson Molly (CFO and CBO) has filed a Form 4 on Phathom Pharmaceuticals, Inc.
Txns: Granted 25,000 shares @ $1, valued at $25k
07/17/2023 4 Curran Terrie (President and Chief Executive) has filed a Form 4 on Phathom Pharmaceuticals, Inc.
Txns: Granted 200,000 shares @ $0
Disposed/sold 175,000 options @ $32.2, valued at $5.6M
Disposed/sold 225,000 options @ $39.11, valued at $8.8M
07/17/2023 4 Nabulsi Azmi (COO) has filed a Form 4 on Phathom Pharmaceuticals, Inc.
Txns: Granted 110,000 shares @ $0
Disposed/sold 70,000 options @ $32.2, valued at $2.3M
Disposed/sold 150,000 options @ $39.11, valued at $5.9M
06/05/2023 4 Parikh Asit (Director) has filed a Form 4 on Phathom Pharmaceuticals, Inc.
Txns: Granted 15,000 shares @ $7.4, valued at $111k
Disposed/sold 15,000 options to buy @ $7.4, valued at $111k
06/05/2023 4 Henderson Molly (CFO and CBO) has filed a Form 4 on Phathom Pharmaceuticals, Inc.
Txns: Sold 1,960 shares @ $11.4121, valued at $22.4k
05/30/2023 4 Topper James N (10% Owner) has filed a Form 4 on Phathom Pharmaceuticals, Inc.
Txns: Granted 9,000 shares @ $0
Granted 15,000 options to buy @ $11.72, valued at $175.8k
05/30/2023 4 Stenhouse Mark (Director) has filed a Form 4 on Phathom Pharmaceuticals, Inc.
Txns: Granted 9,000 shares @ $0
Granted 15,000 options to buy @ $11.72, valued at $175.8k
05/30/2023 4 Socks David A (Director) has filed a Form 4 on Phathom Pharmaceuticals, Inc.
Txns: Granted 9,000 shares @ $0
Granted 15,000 options to buy @ $11.72, valued at $175.8k
05/30/2023 4 Parikh Asit (Director) has filed a Form 4 on Phathom Pharmaceuticals, Inc.
Txns: Granted 9,000 shares @ $0
Granted 15,000 options to buy @ $11.72, valued at $175.8k
05/30/2023 4 FIELDS HEIDI (Director) has filed a Form 4 on Phathom Pharmaceuticals, Inc.
Txns: Granted 9,000 shares @ $0
Granted 15,000 options to buy @ $11.72, valued at $175.8k
05/30/2023 4 KARBE FRANK (Director) has filed a Form 4 on Phathom Pharmaceuticals, Inc.
Txns: Granted 9,000 shares @ $0
Granted 15,000 options to buy @ $11.72, valued at $175.8k
05/30/2023 4 COLA MICHAEL F (Director) has filed a Form 4 on Phathom Pharmaceuticals, Inc.
Txns: Granted 9,000 shares @ $0
Granted 15,000 options to buy @ $11.72, valued at $175.8k
05/23/2023 4 Henderson Molly (CFO and CBO) has filed a Form 4 on Phathom Pharmaceuticals, Inc.
Txns: Sold 2,110 shares @ $12.8744, valued at $27.2k
03/03/2023 4 Henderson Molly (CFO and CBO) has filed a Form 4 on Phathom Pharmaceuticals, Inc.
Txns: Sold 2,032 shares @ $8.5309, valued at $17.3k
02/14/2023 4 Parikh Asit (Director) has filed a Form 4 on Phathom Pharmaceuticals, Inc.
Txns: Bought 5,000 shares @ $7.732, valued at $38.7k
01/20/2023 4 Curran Terrie (President and Chief Executive) has filed a Form 4 on Phathom Pharmaceuticals, Inc.
Txns: Granted 97,500 shares @ $0
Sold 5,821 shares @ $8.1995, valued at $47.7k
Granted 162,500 options to buy @ $8.35, valued at $1.4M
01/20/2023 4 Nabulsi Azmi (COO) has filed a Form 4 on Phathom Pharmaceuticals, Inc.
Txns: Granted 45,000 shares @ $0
Granted 75,000 options to buy @ $8.35, valued at $626.3k
01/20/2023 4 Henderson Molly (CFO and CBO) has filed a Form 4 on Phathom Pharmaceuticals, Inc.
Txns: Granted 33,000 shares @ $0
Granted 55,000 options to buy @ $8.35, valued at $459.3k
01/12/2023 4 Parikh Asit (Director) has filed a Form 4 on Phathom Pharmaceuticals, Inc.
Txns: Bought 5,000 shares @ $7, valued at $35k
11/23/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/23/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/26/2022 4 Topper James N (10% Owner) has filed a Form 4 on Phathom Pharmaceuticals, Inc.
Txns: Granted 20,000 options to buy @ $10.02, valued at $200.4k
09/02/2022 4 Curran Terrie (President and Chief Executive) has filed a Form 4 on Phathom Pharmaceuticals, Inc.
Txns: Granted 7,500 shares @ $0
09/02/2022 4 Nabulsi Azmi (COO) has filed a Form 4 on Phathom Pharmaceuticals, Inc.
Txns: Granted 7,500 shares @ $0
09/02/2022 4 Henderson Molly (CFO and CBO) has filed a Form 4 on Phathom Pharmaceuticals, Inc.
Txns: Granted 7,500 shares @ $0
05/27/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/27/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/27/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/27/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/27/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/27/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/20/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/20/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy